A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Trial Identifier:	D5670C00021
Sponsor:	MedImmune, LLC
NCTID::	NCT03596177
Start Date:	September 2018
Primary Completion Date:	December 2019
Study Completion Date:	December 2019
Condition:	Obesity

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Cambridge, GB, CB2 0QQ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.